Kim et al. [174] investigated PD-L1 immunostaining expression on tumor and non-tumoral cells, as well as the presence of PD-1+ and CD8+ tumor-infiltrating lymphocytes (TILs). The gene discussed is CD274; the disease is neoplasm.